ARTICLE | Company News
Amgen, TranXenoGen antibody deal
September 7, 2001 7:00 AM UTC
TranXenoGen (LSE:TXN) will use its avian transgenic technology to study the feasibility of using transgenic chickens to produce an undisclosed antibody gene from AMGN. Separately, TXN said that Steve ...